Transobturator sling is well tolerated by patients
December 1st 2004San Diego--Preliminary experience with the transobturator sling suggests that it provides a minimally invasive approach to incontinence surgery and that the surgery is well tolerated, a Seattle urologist reported at the AUA Western Section meeting. Complications have been minimal, but the results achieved to date require validation in a prospective clinical trial.
Spiral sling effective as SUI salvage therapy
December 1st 2004San Diego--The spiral sling offers an effective salvage therapy for a select group of difficult stress incontinence patients who have typically failed multiple anti-incontinence procedures, according to an initial experience with the procedure at UCLA.
Cadaveric sling shows solid long-term results
December 1st 2004San Diego--With follow-up for as long as 5 years, the non-frozen cadaveric transvaginal sling has provided excellent results for treatment of stress urinary incontinence with or without prolapse repair and is associated with minimal morbidity, Los Angeles investigators reported at the AUA Western Section meeting.
Transvaginal mesh sling shows good short-term results
December 1st 2004San Diego--The transvaginal permanent mesh sling provides a safe option with excellent early results for more difficult incontinence patients, such as those with lower leak point pressures or decreased urethral mobility, according to researchers at Virginia Mason Medical Center in Seattle.
Relationship found between LUTS, ED in men with BPH
December 1st 2004San Diego--A moderately strong association has been found between lower urinary tract symptoms and the rate of erectile dysfunction in men with moderate to severe symptoms of BPH and enlarged prostate glands, according to a presentation of data gleaned from the Proscar Long-Term Efficacy and Safety Study (PLESS).
RT is safe in patients with prior penile prosthesis
December 1st 2004San Diego--External beam radiation therapy can be safely initiated in patients who have previously undergone penile prosthesis placement, according to results of a small retrospective study presented at the AUA Western Section annual meeting.
Seed migration unlikely to cause adverse events
December 1st 2004Extraprostatic seed placement during prostate brachytherapy frequently results in seed migration to the thorax. However, this occurrence apparently does not influence dosimetry or cause adverse effects, suggest results of a Mayo Clinic series.
Definition of interstitial cystitis still controversial
December 1st 2004Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.
Definition of interstitial cystitis still controversial
December 1st 2004Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.
How to use 3-D CT as a planning tool for renal surgery
December 1st 2004Radiologic imaging has always played a critical role in the diagnosis, treatment, and follow-up of urologic disease. Advances in three-dimensional imaging using multidetector computerized tomography (MDCT) have made this imaging modality an invaluable diagnostic tool in many aspects of urologic practice.
Dr. Waldbaum named chairman of urology at North Shore University Hospital
November 24th 2004Robert Waldbaum, MD, has been named chairman of urology at North Shore University Hospital in Manhasset, NY. Dr. Waldbaum, who served as director of the hospital's division of urology for 30 years, will be the first chairman of urology at the hospital.
Combination treatment effectively treats overactive bladder symptoms in men
November 24th 2004Combination therapy with extended-release tolterodine tartrate (Detrol LA) and doxazosin mesylate (Cardura) is twice as effective as doxazosin alone in relieving overactive bladder symptoms in men with both bladder obstruction and overactive bladder symptoms, according to a recent study in the British Journal of Urology (2004; 94:817-20).
American Board of Urology to participate in certification maintenance program
November 24th 2004The American Board of Urology is among 24 members of the American Board of Medical Specialties that will participate in a Maintenance of Certification program to ensure all board-certified physicians meet the highest standards of patient care and accountability.
FDA warns that two 'dietary' supplements contain sildenafil
November 11th 2004The FDA has issued a consumer alert for and has stopped the importation of the dietary supplements Actra-Rx and Yilishen, because they contain prescription-strength quantities of sildenafil, the active ingredient in Viagra.
Reimbursement up for urology E&M services, down for surgical procedures
November 11th 2004Reimbursement for urologic evaluation and management services increased by one-half since 1995, while surgical reimbursement rates have decreased by about one-third, according to a study in the November Journal of Urology (2004; 172:1958-62).
Sperm stem cells allow infertile mice to father offspring
November 11th 2004Infertile mice produced sperm and fathered offspring after transplantation of sperm progenitor cells grown in laboratory culture, according to research published in the online edition of Proceedings of the National Academy of Sciences.
Oral agent shows durable improvement in SUI patients
November 1st 2004San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.
Existing anticholinergics show few CNS effects
November 1st 2004San Diego-Two anticholinergic drugs commonly used in the treatment of overactive bladder have similarly low incidences of adverse events affecting the central nervous system, according to an analysis of data from a large randomized trial of the agents.
Intravesical agent shows some promise in treating IC
November 1st 2004Whistler, British Columbia, Canada-Intravesical hyaluronic acid (Cystistat) appears to be a simple, quick therapy for reducing pain, frequency, and nocturia in patients with interstitial cystitis, according to Austrian and Canadian researchers. The agent may also improve radiation-induced cystitis and reduce bacterial cystitis recurrences in patients with recurrent urinary tract infections, said Marc Riviere, MD, senior vice president at Belleville, Ontario-based Bioniche Life Sciences Inc., who presented a series of pilot studies at the Canadian Urological Association annual meeting.
Two PDE-5 inhibitors show good results in diabetics
November 1st 2004Whistler, British Columbia, Canada-In separate studies, Canadian researchers have found that two newer phosphodiesterase type-5 inhibitors improve erectile function in diabetic men, a population in which erectile dysfunction can be difficult to treat.